BACK

BACK

USD

IMAC Holdings Inc. Common Stock

$0.044+0.014 (45.215%)

Precio en Tiempo Real

Healthcare
Medical Care Facilities
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$0.030

Máximo

$0.044

Mínimo

$0.030

Volumen

0.01M

Fundamentos de la Empresa

Capitalización de Mercado

148.1K

Industria

Medical Care Facilities

País

United States

Estadísticas de Negociación

Volumen Promedio

0.38M

Bolsa

PNK

Moneda

USD

Rango de 52 Semanas

Mínimo $0.03Actual $0.044Máximo $4.13

Informe de Análisis de IA

Última actualización: 1 may 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

BACK (IMAC Holdings Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: BACK Generate Date: 2025-05-01 12:59:31

Let's break down what's been happening with IMAC Holdings stock, ticker symbol BACK, based on the latest news, how the price has moved, and what some AI models are predicting.

Recent News Buzz: What's the Vibe?

Looking back at the news from February, the feeling was pretty positive. All the headlines focused on their subsidiary, Ignite Proteomics. They were talking about presenting new data on predicting cancer therapy response, finishing up an acquisition for a breast cancer assay code, and publishing a study showing their protein analysis method was better at predicting therapy outcomes.

Basically, the news was all about progress and potential breakthroughs in their proteomics work, which sounds promising for the company's future business prospects in the medical field.

Price Check: What's the Stock Been Doing?

Now, let's look at the stock price itself over the last couple of months. This is where things get a bit dramatic.

Back in early February, the stock was trading in the $0.60 to $0.70 range. There was a noticeable jump and high volume around February 10th, right when one of those positive news stories hit, but it didn't hold. The price then started a slow slide downwards through late February and into March.

Then came a really big event around March 25th. The price absolutely collapsed, dropping from the $0.40s down into the $0.10s and quickly settling into a range between $0.04 and $0.07. Volume spiked massively on that day, suggesting a major shift happened. Since then, the price has stayed very low, hovering right around $0.04, and trading volume has been quite thin compared to earlier in the year.

So, while the news from February was positive, the price action since late March tells a story of a significant downturn and the stock now trading at very low levels.

Interestingly, an AI prediction model sees some small upward movement from this low point. It's predicting percentage increases over the next few days: about 3.1% today, 2.7% tomorrow, and 3.4% the day after. These are small gains in terms of actual dollars, given the current price is just pennies.

Putting It Together: Outlook & Ideas

Okay, so we have positive news from a while back, a recent sharp price collapse, and an AI predicting tiny gains from the current low price. What does this picture suggest?

The dominant factor right now is clearly that massive price drop and the stock trading near its 52-week low ($0.03). The positive news from February didn't prevent this collapse, which means something else likely drove the price down so hard (perhaps related to the company's structure or finances, though the provided data doesn't specify).

Given the history, this stock looks highly volatile and carries significant risk, as the recommendation data also points out (listing "Extreme Volatility," "Small Market Capitalization," and "Low Trading Volume" as risk factors). The company description also notes they "do not have significant operations" currently, which helps explain the low market cap and potential instability.

However, the AI model is predicting small upward moves from this rock-bottom price. The recommendation data also flags some potentially bullish technical signals like a MACD crossover and an increase in trading volume (though remember, that volume is relative to the recent very low levels). It also mentions the stock being potentially undervalued based on a negative P/E (which isn't a standard value metric) and positive news sentiment (referring to the older news).

Apparent Near-Term Leaning: Based purely on the recent price stability at a very low level and the AI predicting small upward ticks, there's a slight leaning towards a potential bounce from this low base. But this is incredibly speculative due to the recent price history and company context. It definitely doesn't favor sellers at this point, as the price has already crashed. It might favor extreme risk-takers looking for a tiny bounce, or warrant patience to see if the price can stabilize or show more significant signs of life.

Potential Entry Consideration: If someone were considering this stock despite the risks, the current price area, around $0.04, is where the AI predicts a potential bounce could start. The recommendation data also lists $0.04 and $0.06 as potential entry points. This looks like a potential level where buyers might step in, simply because it's so low and near the recent bottom.

Potential Exit/Stop-Loss Consideration: Managing risk is absolutely critical here. The recommendation suggests a stop-loss at $0.038. This is a very tight stop, just below the recent low, designed to limit losses if the price dips further. For taking profits, the recommendation suggests $0.07. This aligns with the higher end of the recent trading range since the collapse. These levels are just ideas based on the provided data for managing a potentially volatile trade.

Company Context

It's important to remember that IMAC Holdings is a very small company (tiny market cap) and, according to the description, doesn't currently have significant operations. This makes the stock highly sensitive to any news, positive or negative, and contributes to the extreme volatility we've seen. The positive news from February was about a subsidiary's progress, which is good, but the overall company situation seems challenging based on the price action and description.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing is risky, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Noticias Relacionadas

GlobeNewswire

Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference

Golden, CO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (NASDAQ:BACK), today announced the presentation of new data demonstrating that MHC-II protein expression is a

Ver más
Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference
GlobeNewswire

Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay

Golden, CO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (NASDAQ:BACK), today announced the completed transfer of Proprietary Laboratory Analyses (PLA) code 0249U –

Ver más
Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay
GlobeNewswire

Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response

The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection. Golden, CO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc.

Ver más
Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response

Predicción de IABeta

Recomendación de IA

Alcista

Actualizado el: 5 may 2025, 07:26

BajistaNeutralAlcista

73.2% Confianza

Riesgo y Negociación

Nivel de Riesgo5/5
Riesgo Alto
Adecuado Para
ValorAgresivo
Guía de Negociación

Punto de Entrada

$0.04

Toma de Ganancias

$0.08

Stop Loss

$0.04

Factores Clave

El precio actual está 14.4% por encima de la MA(20) en $0.04
PDI 49.5 está por encima de MDI 37.4 con ADX 18.2, lo que sugiere una tendencia alcista
El MACD -0.0012 está por encima de la línea de señal -0.0022, lo que indica un cruce alcista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.